Our Research

Advance Research

Conquering and curing brain tumors – once and for all.

From basic science to clinical trial designs, the National Brain Tumor Society partners with the world’s leaders in research, public policy, and clinical care to advance the understanding of brain tumors, expand the availability of new treatments, and drive the discovery of a cure. With targeted programs for both adult and pediatric brain tumors, as well as other strategic initiatives to improve access and approvals of newfound discoveries, we drive bold, innovative programs to ensure a brighter future.

Integrated Initiatives

Integrated Initiatives

Uniquely poised to drive change and progress throughout the drug discovery and development pipeline, our initiatives and programs further knowledge and deliver results to our community.

Our funding strategy

Our Funding Strategy

Driven by the needs of this community, we have funded more than $38 million dollars of promising and innovative research for both adults and pediatric brain tumors.

Research funding opportunities

Funding Opportunities

Our innovative funding models are designed to support rigorous scientific investigation and drive progress toward treatments and the discovery of a cure.

From the Blog

  • January 7, 2019

    2019 Crystal Ball: Predictions & Hopes for Advances in Brain Tumor Research and Treatments in the New Year

    What should the brain tumor community hope and watch for in the coming year? As we’ve done for the past three years, we’ve reached out to some of the leading experts in the brain tumor scientific and medical field to get their thoughts

    Read More

  • December 31, 2018

    What the Brain Tumor Community Was Reading in 2018

      Below are the “Top 10” most-read stories on the NBTS site over the course of 2018. Included are heartwrenching statements on loss; moving and inspiring portraits of determined patients, survivors, and caregivers; ‘news you

    Read More

  • December 31, 2018

    NBTS Brain Tumor Clinical Trials Report: Q4 2018 (Including Year-End Update on Phase III Trials)

    Brain tumor clinical trials open around the country all the time, and it can be hard for patients and care partners to keep track of new opportunities to consider participation in leading-edge clinical research. This report, generated by

    Read More

More from the blog